at least 9,000 rohingya were killed in rakhine state from august 25 to september 24, according to doctors without borders.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
18 may, 2018, 09:28 | author: denise dawson
.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
.
the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days.
.
.